Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q2 Program Management Update

17 Aug 2020 07:00

RNS Number : 2531W
Randall & Quilter Inv Hldgs Ltd
17 August 2020
 

 

 

Randall & Quilter Investment Holdings Ltd.

 

Q2 Program Management Update

 

17 August 2020

 

Randall & Quilter Investment Holdings Ltd. (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business, for the six months ended 30 June 2020.

 

Highlights

 

· Contracted Premium of $924.5 million (H1 2019: $431.6 million), a 114% increase

 

· Gross Written Premium of $247.2 million (H1 2019: $172.9 million), a 43% increase

 

· Economic Commission Revenue1 of $10.7 million (H1 2019: $5.7 million), an 88% increase

 

· Addition of 10 new programs bringing the total number of active programs to 36 (H1 2019: 26)

 

· Subsequent to the end of Q2 2020, four new programs were signed with Contracted Premium of approximately $200 million, all of which are expected to begin generating Gross Written Premium shortly

 

· Expected to enter the US Excess & Surplus ("E&S") Program Management market in Q4 2020

 

Commenting on the Program Management results, Alan Quilter, Group Chief Executive Officer, said:

 

"In the first half of 2020, our Program Management business, trading under the Accredited banner, continued to grow strongly. Importantly, this business has significant built-in growth through the 36 existing programs and 34 different distribution partners with whom we have secured contracts as of the end of Q2 2020. In addition, the four new programs we signed post the half year, are expected to generate in excess of $200 million of annual recurring Gross Written Premium when they achieve scale over the next 18 months.

 

We continue to see strong demand from new origination partners as existing insurance capacity faces capital challenges given the magnitude of the insured losses from Covid 19. Moreover, due to current market conditions, we expect to enter the US E&S Program Management market, a large addressable market in which we do not presently compete, in Q4 2020, accelerating our original plans. This launch will see Accredited achieve its strategic objective of being a comprehensive program management solutions provider in all its major markets."

 

R&Q will provide a further update on its Program Management business for the nine months ended 30 September 2020 in the fourth quarter.

 

1: Economic Commission Revenue represents the Commission Revenue from insurance policies already bound (written), regardless of the length of the underlying policy period (earned). We believe Economic Commission Revenue is a more appropriate measure of the revenue of the business during periods of high growth, due to larger than normal gap between Gross Written and Gross Earned (IFRS) Premium, and the corresponding fees.

 

 

Ends

Notes to Editors:

 

Randall & Quilter Investment Holdings Ltd.

 

Ken Randall

William Spiegel

 

Tel: +44 (0)7831 145440

Tel: +001 917 826 5877

Numis Securities Limited (Nominated Adviser)

Stuart Skinner / Huw Jeremy

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Stephane Auton

James Thomas

Tel: 020 7408 4090

 

FTI Consulting

Edward Berry

Tom Blackwell

 

 

Tel: 020 3727 1046

 

About Accredited

 

Accredited is R&Q's Program Management business. Operating in the US, UK and Europe, Accredited is the only program carrier that has an AM Best A- credit rating in all these markets. In the US Accredited is licensed in all 50 states and in the UK/Europe it is licensed to write all classes of non-life business.

 

Accredited has also established a fully authorised UK branch to facilitate continued access to the large UK market, post Brexit. This branch will get the full benefit of Accredited Malta's A- rating from AM Best.

 

Accredited's (US) Financial Strength Category increased in 2019 to an AM Best category IX making it one of the highest rated program managers in the US and providing an important support for the business' continued growth.

 

About R&Q

 

R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities.

 

Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.

 

For the financial year ended 31 December 2019 R&Q reported pre-tax profits of over £40 million.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website : www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPFMLTMTJBBLM
Date   Source Headline
10th May 20232:30 pmRNSTR-1: Notification of major holdings
10th May 202311:26 amRNSTR-1: Notification of major holdings
4th Apr 20237:00 amRNSStrategic & Trading Update
31st Mar 20237:00 amRNSAppointment of Non-Executive Chairman
17th Mar 20237:00 amRNSCompletion of Tradesman Sale
3rd Mar 202312:16 pmRNSTR-1: Notification of major holdings
23rd Feb 20237:00 amRNSProgram Management Update and Sale of Tradesman
17th Jan 20237:00 amRNSProgram Management Update
12th Jan 20237:00 amRNSPDMR/Director Shareholding and Total Voting Rights
6th Jan 20237:00 amRNSJoint venture to acquire legacy liabilities
5th Dec 20227:00 amRNSLoss Portfolio Transfer
31st Oct 20227:00 amRNSQ3 2022 Program Management Update
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20229:24 amRNSTR-1: Notification of major holdings
17th Oct 202210:32 amRNSTR-1: Notification of major holdings
3rd Oct 20223:59 pmRNSDirector/PDMR Shareholding
13th Sep 20222:26 pmRNSResult of Special General Meeting
6th Sep 202212:45 pmRNSTR-1: Notification of major holdings
5th Sep 20227:00 amRNSResults for the half year ended 30 June 2022
30th Aug 20227:00 amRNSResponse to Phoenix
24th Aug 20227:00 amRNSNotice of special general meeting
22nd Aug 20227:00 amRNSBoard Appointment
12th Aug 20226:20 pmRNSResponse to requisition
8th Aug 20227:00 amRNSQ2 2022 Program Management Update
2nd Aug 202210:05 amRNSTR-1: notification of major holdings
19th Jul 20227:00 amRNSChange of Company Name
14th Jul 20223:03 pmRNSResult of Annual General Meeting
14th Jul 202212:47 pmRNSTR-1: Notification of major holdings
14th Jul 202212:45 pmRNSTR-1: Notification of major holdings
14th Jul 202210:46 amRNSTR-1: Notification of major holdings
13th Jul 20223:57 pmRNSTR-1: Notification of major holdings
13th Jul 20223:57 pmRNSTR-1: Notification of major holdings
13th Jul 20223:54 pmRNSTR-1: Notification of major holdings
13th Jul 20222:15 pmRNSTR-1: Notification of major holdings
12th Jul 20222:03 pmRNSTR-1: Notification of major holdings
11th Jul 20223:44 pmRNSResults of General Meeting and Open Offer
6th Jul 20223:56 pmRNSTR-1: Notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
1st Jul 20227:00 amRNSTR-1: notification of major holdings
20th Jun 20224:00 pmRNSNotice of Annual General Meeting and Annual Report
17th Jun 20224:30 pmRNSPosting of Circular and Notice of General Meeting
16th Jun 202210:15 amRNSTR-1: notification of major holdings
16th Jun 202210:09 amRNSTR-1: Notification of major holdings
14th Jun 20228:00 amRNSUpdate on Fundraise and Legal Settlement
13th Jun 20227:00 amRNSProposed Placing and Open Offer
13th Jun 20227:00 amRNSResults for the year ended 31 December 2021
30th May 20227:00 amRNSQ1 2022 Program Management Update
25th May 20226:11 pmRNSResult of Special General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.